Article information
Full text is only aviable in PDF
References
[1.]
D.R. Bickers, J. Frank, et al.
The porphyrias.
Dermatology in General Medicine, pp. 1435-1466
[2.]
M. Méndez, M.V. Rossetti, A.M. del C Batlle, V.E. Parera.
The role of inherited and acquired factors in the development of porphyria cutanea tarda in the Argentinean population.
J Am Acad Dermatol, 52 (2005), pp. 417-424
[3.]
J. Frank, P. Poblete-Gutiérrez, R. Weiskirchen, O. Gressner, H.F. Merk, F. Lammert.
Hemochromatosis gene sequence deviations in German patients with porphyria cutanea tarda.
Physiol Res, 5 (2006), pp. 75-83
[4.]
Z.J. Bulaj, J.D. Phillips, R.S. Ajioka, M.R. Franklin, L.M. Griffen, D.J. Guinee, et al.
Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda.
Blood, 95 (2000), pp. 1565-1570
[5.]
H. Sams, M.G. Kiripolsky, L. Bhat, G.P. Stricklin.
Porphyriacutanea tarda, hepatitis C, alcoholism and hemochromatosis: a case report and review of the literature.
Cutis, 73 (2004), pp. 188-190
[6.]
K. Mehrany, L.A. Drage, D.J. Brandhagen, M.R. Pittelkow.
Association of porphyria cutanea tarda with hereditary hemochromatosis.
J Am Acad Dermatol, 51 (2004), pp. 205-211
[7.]
J.J. Brady, H.E. Jackson, A.G. Roberts, R.R. Morgan, S.D. Whatley, G.L. Rowlands.
Co-inheritance of mutation in the uroporphyrinogen decarboxylase and hemochromatosis genes accelerates the onset of porphyria cutanea tarda.
J Invest Dermatol, 115 (2000), pp. 868-874
[8.]
J.N. Feder, A. Gnirke, W. Thomas, Z. Tsuchihashi, D.A. Ruddy, A. Basava, et al.
A novel MHHC class I-like gene is mutated in patients with hereditary haemochromatosis.
Nat Genet, 13 (1996), pp. 399-408
[9.]
L. Soto, A. Vega, V. Goyanes, D. Valverde.
Hemochromatosis in Galicia (NW Spain) a Celtic influence?.
Clin Genet, 57 (2000), pp. 454-455
[10.]
M. González-Hevilla, R.E. de Salamanca, P. Morales, J. Martínez-Laso, A. Fontanellas, M.J. Castro, et al.
Human leukocyte antigen haplotypes and HFE mutations in Spanish hereditary hemochromatosis and sporadic porphyria cutanea tarda.
J Gastroenterol Hepatol, 20 (2005), pp. 456-462
[11.]
A.G. Roberts, S.D. Whatley, R.R. Morgan, M. Worwood, G.H. Elder.
Increased frequency of the haemocromatosis Cys282 Tyr mutation in sporadic porphyria cutanea tarda.
Lancet, 349 (1997), pp. 321-323
[12.]
M. Santos, H.C. Clevers, J.J. Marx.
Mutations of the hereditary hemochromatosis candidate gene HLA-H in porphyria cutanea tarda.
N Engl J Med, 336 (1997), pp. 1327-1328
[13.]
M. Sanpietro, A. Piperno, L. Lupica, C. Arosio, A. Vergani, N. Corbetta, et al.
High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda.
Hepatology, 27 (1998), pp. 181-184
[14.]
A.L. Martinelli, M.A. Zago, A.M. Roselino, A.B. Filho, M.G. Villanova, M. Secaf, et al.
Porphyria cutanea tarda in Brazilian patients: association with hemochromatosis C282Y mutation and hepatitis C virus infection.
Am J Gastroenterol, 95 (2000), pp. 3516-3521
[15.]
C. Chiaverini, G. Halimi, D. Ouzan, P. Halfon, J.P. Ortonne, J.P. Lacour.
Porphyria cutanea tarda, C282Y, H63D and S65C HFE gene mutations and hepatitis C infection: a study from southern France.
Dermatology, 206 (2003), pp. 212-216
[16.]
A. Toll, R. Celis, M.D. Ozalla, M. Bruguera, C. Herrero, M.G. Ercilla.
The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.
JEADV, 20 (2006), pp. 1201-1206
[17.]
M. D’Amato, A. Macri, D. Griso, G. Biolcati, F. Ameglio.
Are His63Asp or Cys282Tyr HFE mutations associated with porphyria cutanea tarda? Data of patients from central and southern Italy.
J Invest Dermatol, 111 (1998), pp. 1241-1242
[18.]
R.P.E. Sarkany.
The management of porphyria cutanea tarda.
Clin Exp Dermatol, 26 (2001), pp. 225-232
[19.]
M. Méndez, P. Poblete-Gutiérrez, M. García-Bravo, T. Wiederholt, M.J. Morán-Jiménez, H.F. Merk, et al.
Molecular heterogeneity of familial cutanea tarda in Spain: characterization of 10 novels mutations in the UROD gene.
Br J Dermatol, 157 (2007), pp. 501-507
Copyright © 2009. Academia Española de Dermatología y Venereología and Elsevier España, S.L.
